Clinical Trial Update: Iron Dosing Pilot Study Using Model Predictive Control [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating iron dosing using model predictive control in patients with chronic kidney disease-related anemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia Iron-deficiency
• Anemia of Chronic Kidney Disease
• Renal Insufficiency Chronic

Snippet

Sponsor: University of Louisville | Conditions: Renal Insufficiency, Chronic, Anemia, Iron Deficiency | Phase 4 | Status: COMPLETED